Related Experiment Video
Updated: Jun 12, 2026

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
High affinity binding site for (+) amphetamine in rat hypothalamus: Fact or artefact?
A Lesage1, M Strolin Benedetti, J F Rumigny
1Centre de Recherche Delalande, 10 rue des Carrières, F-92500 Rueil-Malmaison, France.
This study reveals potential artifacts in amphetamine binding research due to filtration methods. Monoamine oxidase A may be involved in amphetamine binding sites, as shown by inhibitor displacement experiments.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Amphetamine's interaction with brain receptors is crucial for understanding its effects.
- Previous studies on amphetamine binding sites may be affected by methodological limitations.
Purpose of the Study:
- To investigate the binding of (+)(3)H-amphetamine to rat hypothalamus membrane sites.
- To identify potential artifacts in previous binding studies.
- To explore the role of monoamine oxidase A in amphetamine binding.
Main Methods:
- Radioligand binding assays using (+)(3)H-amphetamine.
- Filtration technique assessment.
- Displacement studies with harmaline and monoamine oxidase A inhibitors.
Main Results:
- Inadequate filtration techniques may lead to artefactual results in amphetamine binding studies.
- (+)(3)H-amphetamine binding is displaced by harmaline and selective monoamine oxidase A inhibitors.
- Monoamine oxidase A appears to be a component of the binding sites for (+)(3)H-amphetamine.
Conclusions:
- The filtration method used in previous studies requires re-evaluation for accuracy.
- Monoamine oxidase A is implicated as a potential binding site or associated protein for amphetamine.
- Further research is needed to fully elucidate the complex interactions of amphetamine with brain membrane sites.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drug Abuse and Addiction: Pharmacological Phenomena

